Lillian Brown, MD, PhD

Assistant Adjunct Professor

HIV, Infectious Disease, and Global Medicine

Education
Residency, 2014 - Medicine, University of California San Francisco
Internship, 2013 - Medicine, University of California San Francisco
M.D., 2012 - School of Medicine, University of North Carolina
PhD, 2010 - School of Public Health, Epidemiology, University of North Carolina
BA, 2001 - Biology, Harvard University
Fellowship, - Infectious Diseases, University of California San Francisco
Publications
  1. A patient-centered multi-component strategy for accelerated linkage to care following community-wide HIV testing in rural Uganda and Kenya.
  2. "Hurdles on the path to 90-90-90 and beyond": Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat.
  3. Costs of streamlined HIV care delivery in rural Ugandan and Kenyan clinics in the search study.
  4. Predictors of Retention in HIV Care Among Youth (15-24) in a Universal Test-and-Treat Setting in Rural Kenya.
  5. High levels of retention in care with streamlined care and universal test and treat in East Africa.
  6. Antimicrobial Resistance: A Call to Action!
  7. Maximizing HIV partner notification opportunities for index patients and their sexual partners in Malawi.
  8. The feasibility of an intensive case management program for injection drug users on antiretroviral therapy in St. Petersburg, Russia.
  9. Cost-effectiveness of provider-based HIV partner notification in urban Malawi.
  10. Predicting partner HIV testing and counseling following a partner notification intervention.
  11. Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test.
  12. HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention.
  13. Viewpoint: Gentamicin for treatment of gonococcal urethritis in Malawi.
  14. Accelerating worldwide syphilis screening through rapid testing: a systematic review.
  15. Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.
  16. Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007.
  17. Epidemiology of injuries at a tertiary care center in Malawi.
  18. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
  19. Morbidity and mortality among a cohort of human immunodeficiency virus type 1-infected and uninfected pregnant women and their infants from Malawi, Zambia, and Tanzania.
  20. Genetic and environmental influences on bone mineral density in pre- and post-menopausal women.
  21. Assessment of sex-specific genetic and environmental effects on bone mineral density.